These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16142801)

  • 1. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.
    Gong Z; Jin Y; Zhang Y
    Vaccine; 2007 Feb; 25(8):1444-51. PubMed ID: 17113687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes.
    Gong Z; Jin Y; Zhang Y
    J Biotechnol; 2005 Sep; 119(1):93-105. PubMed ID: 16024127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes.
    Arakawa T; Yu J; Chong DK; Hough J; Engen PC; Langridge WH
    Nat Biotechnol; 1998 Oct; 16(10):934-8. PubMed ID: 9788349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides.
    Wang H; Yang J; Jin L; Feng J; Lu Y; Sun Y; Li T; Cao R; Wu J; Fan H; Liu J
    Immunol Invest; 2009; 38(8):690-703. PubMed ID: 19860582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli.
    Gong Z; Long X; Pan L; Le Y; Liu Q; Wang S; Guo J; Xiao B; Zhou M; Mei D
    Protein Expr Purif; 2009 Aug; 66(2):191-7. PubMed ID: 19364533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.
    Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J
    Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2010 Jan; 71(1):1-11. PubMed ID: 20017804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
    Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B.
    Ayalew S; Step DL; Montelongo M; Confer AW
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):295-302. PubMed ID: 19581005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R; Guerau-de-Arellano M; Zhang X; Weiner HL
    J Autoimmun; 2001 Feb; 16(1):21-8. PubMed ID: 11221993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis.
    Yuki Y; Byun Y; Fujita M; Izutani W; Suzuki T; Udaka S; Fujihashi K; McGhee JR; Kiyono H
    Biotechnol Bioeng; 2001 Jul; 74(1):62-9. PubMed ID: 11353411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
    Boberg A; Gaunitz S; Bråve A; Wahren B; Carlin N
    Vaccine; 2008 Sep; 26(40):5079-82. PubMed ID: 18514370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.
    Harakuni T; Sugawa H; Komesu A; Tadano M; Arakawa T
    Infect Immun; 2005 Sep; 73(9):5654-65. PubMed ID: 16113283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
    Aspord C; Thivolet C
    Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J
    Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes.
    Kobayashi M; Abiru N; Arakawa T; Fukushima K; Zhou H; Kawasaki E; Yamasaki H; Liu E; Miao D; Wong FS; Eisenbarth GS; Eguchi K
    J Immunol; 2007 Aug; 179(4):2082-8. PubMed ID: 17675466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases.
    Langridge W; Dénes B; Fodor I
    Curr Opin Investig Drugs; 2010 Aug; 11(8):919-28. PubMed ID: 20721834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.